Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Unsupervised clustering FLIM-phasor from multifunctionalized nanoparticles in living cancer cells.

Methods and applications in fluorescence·2026
Same author

Bioluminescent Probes for Multiplexed RNA Imaging.

Journal of the American Chemical Society·2026
Same author

Unleashed condensation by recurrent mutations of an epigenetic regulator promotes cancer.

bioRxiv : the preprint server for biology·2026
Same author

FLIM intensity-based image segmentation reveals upregulated energy metabolism and chemotherapy sensitivity in MCF-7 cells.

Journal of cell science·2025
Same author

ESPRESSO: spatiotemporal omics based on organelle phenotyping.

Nature methods·2025
Same author

Multimodal Phasor Approach to Study Breast Cancer Cell Invasion in a 3D Spheroid Model.

Chemical & biomedical imaging·2025

Related Experiment Video

Updated: Jun 17, 2026

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

8.1K

A novel imaging-based multi-sample viscometry application for advancing monoclonal antibody development.

Karen L Lopez1, Francesco Palomba1, Marissa Mock2

  • 1Laboratory for Fluorescence Dynamics, Biomedical Engineering Department, University of California, Irvine, CA, United States of America.

Methods and Applications in Fluorescence
|April 10, 2026
PubMed
Summary

A new imaging technique uses fluorescent beads and single particle tracking to rapidly measure monoclonal antibody viscosity. This high-throughput method requires minimal sample volume, accelerating therapeutic development.

Keywords:
fluorescence microscopymonoclonal antibodyviscometers

More Related Videos

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
10:50

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System

Published on: May 1, 2019

15.5K
Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application
04:24

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application

Published on: June 16, 2023

2.5K

Related Experiment Videos

Last Updated: Jun 17, 2026

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

8.1K
Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
10:50

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System

Published on: May 1, 2019

15.5K
Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application
04:24

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application

Published on: June 16, 2023

2.5K

Area of Science:

  • Biotechnology
  • Biophysics
  • Analytical Chemistry

Background:

  • Therapeutic monoclonal antibody (mAb) development is critical but faces bottlenecks in sample testing.
  • Viscosity is a key mAb property impacting drug delivery and patient experience.
  • Existing viscometry methods are slow, require large sample volumes, and lack automation.

Purpose of the Study:

  • To develop and validate a novel, high-throughput, low-volume imaging-based viscometry method for mAb solutions.
  • To address the limitations of traditional viscometry techniques in mAb development.

Main Methods:

  • Integration of a wide-field camera, fluorescence microscope, and Python-based Single Particle Tracking (SPT) software.
  • Utilized 200 nm yellow-green fluorescent polystyrene beads as tracers in low-volume (2 μL) samples.
  • Validated with Bovine Serum Albumin (BSA), viscosity standards, and blinded IgG1/IgG2 solutions (≤150 mg/mL).

Main Results:

  • The SPT method achieved rapid, accurate macroviscosity measurements.
  • Blinded analysis of IgG solutions showed a high linear fit (R² = 0.97) with an average error of 2.1 cP compared to unblinded values.
  • Demonstrated high-throughput capability and precision.

Conclusions:

  • The novel imaging-based viscometry platform significantly streamlines mAb development by overcoming throughput and sample volume limitations.
  • This method offers a cost-effective and efficient solution for a pressing challenge in the biopharmaceutical industry.
  • Enables faster optimization of mAb properties for improved therapeutic agents.